What Researchers Did
Researchers evaluated the therapeutic effect of hyperbaric oxygen (HBO) treatment for idiopathic sudden deafness by analyzing 236 inpatient medical records from 1997-2004, comparing HBO and non-HBO groups.
What They Found
Multivariate analysis revealed that the hyperbaric oxygen (HBO) group achieved a significantly higher effective ratio, with hearing threshold elevated above 15 dB, compared to the non-HBO group (P<0.01). Factors such as age, course of deafness, presence of vertigo, and degree of deafness influenced prognosis, while a first visit after 14 days, vertigo, and complete deafness indicated poor outcomes.
What This Means for Canadian Patients
Canadian patients experiencing idiopathic sudden deafness may benefit from hyperbaric oxygen (HBO) therapy, as it was found to significantly improve hearing thresholds. Seeking treatment promptly, ideally within 14 days of onset, could be important for achieving better recovery outcomes.
Canadian Relevance
This study was conducted in Wuhan, China, and has no direct Canadian connection.
Study Limitations
As a retrospective study from a single hospital, these findings may be subject to selection bias and might not be generalizable to all populations.